These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 26955956)

  • 1. NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?
    Friberg S; Nyström AM
    J Nanobiotechnology; 2016 Mar; 14():17. PubMed ID: 26955956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using nanotechnology to progress the utilization of marine natural products in combating multidrug resistance in cancer: A prospective strategy.
    Bhusare N; Gade A; Kumar MS
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23732. PubMed ID: 38769657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer.
    Haider M; Elsherbeny A; Pittalà V; Consoli V; Alghamdi MA; Hussain Z; Khoder G; Greish K
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer chemoprevention by polyphenols and their potential application as nanomedicine.
    Tabrez S; Priyadarshini M; Urooj M; Shakil S; Ashraf GM; Khan MS; Kamal MA; Alam Q; Jabir NR; Abuzenadah AM; Chaudhary AG; Damanhouri GA
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(1):67-98. PubMed ID: 23534395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle carriers for combating multidrug-resistant cancer.
    Yan Y; Björnmalm M; Caruso F
    ACS Nano; 2013 Nov; 7(11):9512-7. PubMed ID: 24215340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine against multidrug resistance in cancer treatment.
    Gao J; Feng SS; Guo Y
    Nanomedicine (Lond); 2012 Apr; 7(4):465-8. PubMed ID: 22471716
    [No Abstract]   [Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationally designed nanovehicles to overcome cancer chemoresistance.
    Livney YD; Assaraf YG
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1716-30. PubMed ID: 23954781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells.
    Shi Q; Zhang L; Liu M; Zhang X; Zhang X; Xu X; Chen S; Li X; Zhang J
    Biomaterials; 2015 Oct; 67():169-82. PubMed ID: 26218743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
    Iyer AK; Duan Z; Amiji MM
    Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanosensors for early cancer detection and for therapeutic drug monitoring.
    Salvati E; Stellacci F; Krol S
    Nanomedicine (Lond); 2015; 10(23):3495-512. PubMed ID: 26606949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedical engineering: shaping future nanomedicines.
    Luo D; Carter KA; Lovell JF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):169-88. PubMed ID: 25377691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology-based intelligent drug design for cancer metastasis treatment.
    Gao Y; Xie J; Chen H; Gu S; Zhao R; Shao J; Jia L
    Biotechnol Adv; 2014; 32(4):761-77. PubMed ID: 24211475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomedical nanotechnology for cancer.
    Pope-Harman A; Cheng MM; Robertson F; Sakamoto J; Ferrari M
    Med Clin North Am; 2007 Sep; 91(5):899-927. PubMed ID: 17826110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.